BIO Investor Forum Opens Amid Positive Signs for Emerging Biotechs

Today the BIO Investor Forum opens in San Francisco amid optimism in the biotech sector. Venture investment is outpacing last year; the NASDAQ Biotech Index is up 38 percent since the election; and stocks of small, clinical-stage biotechs – those with no approved products – are up 78 percent.
In 2017, innovation is advancing at a breathtaking pace – with the U.S. Food and Drug Administration (FDA) recently approving its first-ever CAR-T cell therapy for an untreatable form of c